DHA

Dha is a lipid of Fatty Acyls (FA) class. Dha is associated with abnormalities such as Atherosclerosis, Consumption-archaic term for TB, Chronic disease, Cardiovascular Diseases and Diabetes Mellitus, Non-Insulin-Dependent. The involved functions are known as Inflammation, Oxidation, fatty acid oxidation, Fatty Acid Metabolism and Lipid Metabolism. Dha often locates in Hepatic, Protoplasm, Mucous Membrane, Epithelium and outer membrane. The associated genes with DHA are IMPACT gene, FATE1 gene, GAPDH gene, THOC4 gene and SLC33A1 gene. The related lipids are stearidonic acid, Fatty Acids, Total cholesterol, Lipopolysaccharides and Dietary Fatty Acid. The related experimental models are Mouse Model, Transgenic Model, Animal Disease Models and Arthritis, Experimental.

Cross Reference

Introduction

To understand associated biological information of DHA, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with DHA?

DHA is suspected in Cardiovascular Diseases, Obesity, Ischemia, Hypertensive disease, Coronary Arteriosclerosis, Cerebrovascular accident and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with DHA

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Stomach Ulcer D013276 75 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Hypoxia D000860 23 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Adenocarcinoma D000230 166 associated lipids
Breast Neoplasms D001943 24 associated lipids
Pain D010146 64 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Lung Diseases D008171 37 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Burns D002056 34 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Inflammation D007249 119 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colitis D003092 69 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetic Retinopathy D003930 39 associated lipids
Fatty Liver D005234 48 associated lipids
Cataract D002386 34 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Precancerous Conditions D011230 48 associated lipids
Carcinoma D002277 18 associated lipids
Hypotension D007022 41 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Dementia D003704 2 associated lipids
Heart Failure D006333 36 associated lipids
Coronary Disease D003327 70 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Hypersensitivity D006967 22 associated lipids
Brain Neoplasms D001932 15 associated lipids
Hypothyroidism D007037 32 associated lipids
Vision Disorders D014786 10 associated lipids
Melanoma D008545 69 associated lipids
Pain, Postoperative D010149 13 associated lipids
Asthma D001249 52 associated lipids
Kidney Diseases D007674 29 associated lipids
Weight Gain D015430 101 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Glioma D005910 112 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Per page 10 20 50 100 | Total 240

PubChem Associated disorders and diseases

What pathways are associated with DHA

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with DHA?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with DHA?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with DHA?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with DHA?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with DHA?

Mouse Model

Mouse Model are used in the study 'Homeostatic regulation of photoreceptor cell integrity: significance of the potent mediator neuroprotectin D1 biosynthesized from docosahexaenoic acid: the Proctor Lecture.' (Bazan NG, 2007), Mouse Model are used in the study 'Omega-3 fatty acids EPA and DHA: health benefits throughout life.' (Swanson D et al., 2012), Mouse Model are used in the study 'Docosahexaenoic acid attenuates hepatic inflammation, oxidative stress, and fibrosis without decreasing hepatosteatosis in a Ldlr(-/-) mouse model of western diet-induced nonalcoholic steatohepatitis.' (Depner CM et al., 2013) and Mouse Model are used in the study 'Wax esters from the marine copepod Calanus finmarchicus reduce diet-induced obesity and obesity-related metabolic disorders in mice.' (Höper AC et al., 2014).

Transgenic Model

Transgenic Model are used in the study 'Loss of MAP function leads to hippocampal synapse loss and deficits in the Morris Water Maze with aging.' (Ma QL et al., 2014).

Animal Disease Models

Animal Disease Models are used in the study 'Fish oil increases muscle protein mass and modulates Akt/FOXO, TLR4, and NOD signaling in weanling piglets after lipopolysaccharide challenge.' (Liu Y et al., 2013).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with DHA

Download all related citations
Per page 10 20 50 100 | Total 7336
Authors Title Published Journal PubMed Link
Innis SM Essential fatty acid transfer and fetal development. 2005 Placenta pmid:15837071
Johnsen GM et al. Docosahexaenoic acid stimulates tube formation in first trimester trophoblast cells, HTR8/SVneo. 2011 Placenta pmid:21741084
Xu Y et al. Maternal di-(2-ethylhexyl)-phthalate exposure influences essential fatty acid homeostasis in rat placenta. 2008 Placenta pmid:18829104
Johnsen GM et al. Long-chain polyunsaturated fatty acids stimulate cellular fatty acid uptake in human placental choriocarcinoma (BeWo) cells. 2009 Placenta pmid:19880178
Tobin KA et al. Long-chain polyunsaturated fatty acid transport across human placental choriocarcinoma (BeWo) cells. 2009 Placenta pmid:19010540
Guihéneuf F et al. Use of radiolabeled substrates to determine the desaturase and elongase activities involved in eicosapentaenoic acid and docosahexaenoic acid biosynthesis in the marine microalga Pavlova lutheri. 2013 Phytochemistry pmid:23528573
Mansour MP et al. The effect of growth phase on the lipid class, fatty acid and sterol composition in the marine dinoflagellate, Gymnodinium sp. in batch culture. 2003 Phytochemistry pmid:12711135
Zhou XR et al. Isolation and characterization of genes from the marine microalga Pavlova salina encoding three front-end desaturases involved in docosahexaenoic acid biosynthesis. 2007 Phytochemistry pmid:17291553
Georgiadi A et al. Detailed transcriptomics analysis of the effect of dietary fatty acids on gene expression in the heart. 2012 Physiol. Genomics pmid:22274564
Turner N et al. Scaling of Na+,K+-ATPase molecular activity and membrane fatty acid composition in mammalian and avian hearts. 2006 May-Jun Physiol. Biochem. Zool. pmid:16691518
Levant B et al. Developmental effects of dietary n-3 fatty acids on activity and response to novelty. 2010 Physiol. Behav. pmid:20457171
Correia Bacarin C et al. Fish oil provides robust and sustained memory recovery after cerebral ischemia: influence of treatment regimen. 2013 Physiol. Behav. pmid:23770426
Trofimiuk E and Braszko JJ Concomitant docosahexaenoic acid administration ameliorates stress-induced cognitive impairment in rats. 2013 Physiol. Behav. pmid:23672853
Bandaru SS et al. Effects of PI3K inhibition and low docosahexaenoic acid on cognition and behavior. 2010 Physiol. Behav. pmid:19914265
Kunesová M et al. The influence of n-3 polyunsaturated fatty acids and very low calorie diet during a short-term weight reducing regimen on weight loss and serum fatty acid composition in severely obese women. 2006 Physiol Res pmid:15857162
Easley JT et al. AT-RvD1 combined with DEX is highly effective in treating TNF-α-mediated disruption of the salivary gland epithelium. 2016 Physiol Rep pmid:27694530
Gederaas OA et al. Cell specific effects of polyunsaturated fatty acids on 5-aminolevulinic acid based photosensitization. 2005 Photochem. Photobiol. Sci. pmid:15803209
Kello M et al. PUFAs enhance oxidative stress and apoptosis in tumour cells exposed to hypericin-mediated PDT. 2010 Photochem. Photobiol. Sci. pmid:20714672
Du J et al. Palmitic acid and docosahexaenoic acid opposingly regulate the expression of insulin-degrading enzyme in neurons. 2010 Pharmazie pmid:20383947
Burns T et al. Effect of omega-3 fatty acid supplementation on the arachidonic acid:eicosapentaenoic acid ratio. 2007 Pharmacotherapy pmid:17461697
McKenney JM and Sica D Role of prescription omega-3 fatty acids in the treatment of hypertriglyceridemia. 2007 Pharmacotherapy pmid:17461707
Sametz W et al. Influence of polyunsaturated fatty acids on vasoconstrictions induced by 8-iso-PGF(2alpha) and 8-iso-PGE(2). 2000 Pharmacology pmid:10754452
Schjøtt J et al. Effects of eicosapentaenoic acid and docosahexaenoic acid diet supplement on tolerance to the cardiotoxicity of epirubicin and to ischaemia reperfusion in the isolated rat heart. 1996 Pharmacol. Toxicol. pmid:8878248
Paulsen JE et al. A fish oil-derived concentrate enriched in eicosapentaenoic and docosahexaenoic acid as ethyl esters inhibits the formation and growth of aberrant crypt foci in rat colon. 1998 Pharmacol. Toxicol. pmid:9527643
Gorjão R et al. Comparative effects of DHA and EPA on cell function. 2009 Pharmacol. Ther. pmid:19318040
Obajimi O et al. Differential effects of eicosapentaenoic and docosahexaenoic acids upon oxidant-stimulated release and uptake of arachidonic acid in human lymphoma U937 cells. 2005 Pharmacol. Res. pmid:15967385
Galli C Health implications of DHA. 1999 Pharmacol. Res. pmid:10479461
Lagarde M Health benefits of docosahexaenoic acid (DHA) 1999 Pharmacol. Res. pmid:10479462
Horrocks LA and Yeo YK Health benefits of docosahexaenoic acid (DHA) 1999 Pharmacol. Res. pmid:10479465
Lopez-Huertas E Health effects of oleic acid and long chain omega-3 fatty acids (EPA and DHA) enriched milks. A review of intervention studies. 2010 Pharmacol. Res. pmid:19897038
Rogers LK et al. DHA supplementation: current implications in pregnancy and childhood. 2013 Pharmacol. Res. pmid:23266567
Yetimler B et al. Differential effect of age on the brain fatty acid levels and their correlation with animal cognitive status in mice. 2012 Pharmacol. Biochem. Behav. pmid:22878041
Cao DH et al. Protective effect of chronic ethyl docosahexaenoate administration on brain injury in ischemic gerbils. 2004 Pharmacol. Biochem. Behav. pmid:15582673
Minami M et al. Dietary docosahexaenoic acid increases cerebral acetylcholine levels and improves passive avoidance performance in stroke-prone spontaneously hypertensive rats. 1997 Pharmacol. Biochem. Behav. pmid:9408223
Arnold C et al. Cytochrome P450-dependent metabolism of omega-6 and omega-3 long-chain polyunsaturated fatty acids. 2010 May-Jun Pharmacol Rep pmid:20631419
Mussi SV et al. Novel nanostructured lipid carrier co-loaded with doxorubicin and docosahexaenoic acid demonstrates enhanced in vitro activity and overcomes drug resistance in MCF-7/Adr cells. 2014 Pharm. Res. pmid:24522814
Hörcher U [Omega-3-fatty acids from fish oil for the prevention of myocardial infarct]. 1988 Pharm Unserer Zeit pmid:2840674
Jiang LH et al. Oral administration of docosahexaenoic acid activates the GDNF-MAPK-CERB pathway in hippocampus of natural aged rat. 2013 Pharm Biol pmid:23767459
Bueno AA et al. Effects of different fatty acids and dietary lipids on adiponectin gene expression in 3T3-L1 cells and C57BL/6J mice adipose tissue. 2008 Pflugers Arch. pmid:17717684
Makrides M et al. A critical appraisal of the role of dietary long-chain polyunsaturated fatty acids on neural indices of term infants: a randomized, controlled trial. 2000 Pediatrics pmid:10617701
Scott DT et al. Formula supplementation with long-chain polyunsaturated fatty acids: are there developmental benefits? 1998 Pediatrics pmid:9794989
Mizejewski GJ and Pass KA Fatty acids, alpha-fetoprotein, and cystic fibrosis. 2001 Pediatrics pmid:11731663
O'Connor DL et al. Growth and development in preterm infants fed long-chain polyunsaturated fatty acids: a prospective, randomized controlled trial. 2001 Pediatrics pmid:11483801
Auestad N et al. Growth and development in term infants fed long-chain polyunsaturated fatty acids: a double-masked, randomized, parallel, prospective, multivariate study. 2001 Pediatrics pmid:11483802
Manley BJ et al. High-dose docosahexaenoic acid supplementation of preterm infants: respiratory and allergy outcomes. 2011 Pediatrics pmid:21708809
Imhoff-Kunsch B et al. Prenatal docosahexaenoic acid supplementation and infant morbidity: randomized controlled trial. 2011 Pediatrics pmid:21807696
Clandinin MT and VanAerde J Formula supplementation and growth. 2003 Pediatrics pmid:14654632
Auestad N et al. Visual, cognitive, and language assessments at 39 months: a follow-up study of children fed formulas containing long-chain polyunsaturated fatty acids to 1 year of age. 2003 Pediatrics pmid:12949309
D'Vaz N et al. Postnatal fish oil supplementation in high-risk infants to prevent allergy: randomized controlled trial. 2012 Pediatrics pmid:22945403
Isaacs EB et al. 10-year cognition in preterms after random assignment to fatty acid supplementation in infancy. 2011 Pediatrics pmid:21930549
Henriksen C et al. Improved cognitive development among preterm infants attributable to early supplementation of human milk with docosahexaenoic acid and arachidonic acid. 2008 Pediatrics pmid:18519483
Makrides M et al. Dietary long-chain polyunsaturated fatty acids do not influence growth of term infants: A randomized clinical trial. 1999 Pediatrics pmid:10469771
Helland IB et al. Similar effects on infants of n-3 and n-6 fatty acids supplementation to pregnant and lactating women. 2001 Pediatrics pmid:11694666
Murakami K et al. Fish and n-3 polyunsaturated fatty acid intake and depressive symptoms: Ryukyus Child Health Study. 2010 Pediatrics pmid:20713476
Beblo S et al. Effects of alcohol intake during pregnancy on docosahexaenoic acid and arachidonic acid in umbilical cord vessels of black women. 2005 Pediatrics pmid:15687427
Krugman S and Law P Breastfeeding and IQ. 1999 Pediatrics pmid:9988628
Pawlik D et al. Fish-oil fat emulsion supplementation may reduce the risk of severe retinopathy in VLBW infants. 2011 Pediatrics pmid:21199856
Sweeney B et al. Polyunsaturated fatty acids influence neonatal monocyte survival. 2001 Pediatr. Surg. Int. pmid:11409157
Llanos A et al. Infants with intrauterine growth restriction have impaired formation of docosahexaenoic acid in early neonatal life: a stable isotope study. 2005 Pediatr. Res. pmid:16189202
Agostoni C and Verduci E DHA in pregnancy benefits child development. 2003 Pediatr. Res. pmid:12904586
Liu CC et al. Increase in plasma phospholipid docosahexaenoic and eicosapentaenoic acids as a reflection of their intake and mode of administration. 1987 Pediatr. Res. pmid:2821474
Woods J et al. Is docosahexaenoic acid necessary in infant formula? Evaluation of high linolenate diets in the neonatal rat. 1996 Pediatr. Res. pmid:8910933
Lauritzen L et al. Maternal fish oil supplementation in lactation and growth during the first 2.5 years of life. 2005 Pediatr. Res. pmid:16006428
Ponder DL et al. Docosahexaenoic acid status of term infants fed breast milk or infant formula containing soy oil or corn oil. 1992 Pediatr. Res. pmid:1287559
Curatolo N et al. Oral administration of docosahexaenoic acid/eicosapentaeinoic acids is not anticonvulsant in rats: implications for translational research. 2011 Pediatr. Res. pmid:21857379
Greiner RC et al. Brain docosahexaenoate accretion in fetal baboons: bioequivalence of dietary alpha-linolenic and docosahexaenoic acids. 1997 Pediatr. Res. pmid:9396565
Salem N What is the right level of DHA in the infant diet? Commentary on article by Hsieh et al. on page 537. 2007 Pediatr. Res. pmid:17413853
Hsieh AT et al. The influence of moderate and high dietary long chain polyunsaturated fatty acids (LCPUFA) on baboon neonate tissue fatty acids. 2007 Pediatr. Res. pmid:17413857
Lim SY et al. N-3 fatty acid deficiency induced by a modified artificial rearing method leads to poorer performance in spatial learning tasks. 2005 Pediatr. Res. pmid:16189203
Colombo J et al. Long-chain polyunsaturated fatty acid supplementation in infancy reduces heart rate and positively affects distribution of attention. 2011 Pediatr. Res. pmid:21705959
Farquharson J et al. Age- and dietary-related distributions of hepatic arachidonic and docosahexaenoic acid in early infancy. 1995 Pediatr. Res. pmid:7494660
Sauerwald TU et al. Intermediates in endogenous synthesis of C22:6 omega 3 and C20:4 omega 6 by term and preterm infants. 1997 Pediatr. Res. pmid:9029636
García-Calatayud S et al. Brain docosahexaenoic acid status and learning in young rats submitted to dietary long-chain polyunsaturated fatty acid deficiency and supplementation limited to lactation. 2005 Pediatr. Res. pmid:15718358
Lefkowitz W et al. Where does the developing brain obtain its docosahexaenoic acid? Relative contributions of dietary alpha-linolenic acid, docosahexaenoic acid, and body stores in the developing rat. 2005 Pediatr. Res. pmid:15531740
Mollard RC and Weiler HA Dietary arachidonic acid and docosahexaenoic acid elevate femur calcium and reduce zinc content in piglets. 2006 Pediatr. Res. pmid:16940244
Su HM et al. Bioequivalence of dietary alpha-linolenic and docosahexaenoic acids as sources of docosahexaenoate accretion in brain and associated organs of neonatal baboons. 1999 Pediatr. Res. pmid:9890614
Bouwstra H et al. Neurologic condition of healthy term infants at 18 months: positive association with venous umbilical DHA status and negative association with umbilical trans-fatty acids. 2006 Pediatr. Res. pmid:16857765
Damsgaard CT et al. The effects of n-3 long-chain polyunsaturated fatty acids on bone formation and growth factors in adolescent boys. 2012 Pediatr. Res. pmid:22337227
Anderson GJ et al. Docosahexaenoic acid is the preferred dietary n-3 fatty acid for the development of the brain and retina. 1990 Pediatr. Res. pmid:2136947
Champoux M et al. Fatty acid formula supplementation and neuromotor development in rhesus monkey neonates. 2002 Pediatr. Res. pmid:11861930
Lapillonne A et al. The use of low-EPA fish oil for long-chain polyunsaturated fatty acid supplementation of preterm infants. 2000 Pediatr. Res. pmid:11102555
Larqué E et al. Dietary trans fatty acids affect docosahexaenoic acid concentrations in plasma and liver but not brain of pregnant and fetal rats. 2000 Pediatr. Res. pmid:10674359
Bowen RA et al. Does increasing dietary linolenic acid content increase the docosahexaenoic acid content of phospholipids in neuronal cells of neonatal rats? 1999 Pediatr. Res. pmid:10367771
Sarkadi-Nagy E et al. The influence of prematurity and long chain polyunsaturate supplementation in 4-week adjusted age baboon neonate brain and related tissues. 2003 Pediatr. Res. pmid:12736388
Makrides M et al. Erythrocyte docosahexaenoic acid correlates with the visual response of healthy, term infants. 1993 Pediatr. Res. pmid:8479826
Birch EE et al. Visual acuity and the essentiality of docosahexaenoic acid and arachidonic acid in the diet of term infants. 1998 Pediatr. Res. pmid:9702915
Carlson SE et al. Effect of fish oil supplementation on the n-3 fatty acid content of red blood cell membranes in preterm infants. 1987 Pediatr. Res. pmid:2954026
Dunstan JA et al. The effects of fish oil supplementation in pregnancy on breast milk fatty acid composition over the course of lactation: a randomized controlled trial. 2007 Pediatr. Res. pmid:17957152
Carlson SE et al. Long-term feeding of formulas high in linolenic acid and marine oil to very low birth weight infants: phospholipid fatty acids. 1991 Pediatr. Res. pmid:1684416
Carlson SE et al. Visual acuity and fatty acid status of term infants fed human milk and formulas with and without docosahexaenoate and arachidonate from egg yolk lecithin. 1996 Pediatr. Res. pmid:8726246
Morris SA et al. Developmental sensitivity of the piglet brain to docosahexanoic acid. 1999 Pediatr. Res. pmid:10509359
Cetin I et al. Intrauterine growth restriction is associated with changes in polyunsaturated fatty acid fetal-maternal relationships. 2002 Pediatr. Res. pmid:12409524
Clandinin MT et al. Assessment of the efficacious dose of arachidonic and docosahexaenoic acids in preterm infant formulas: fatty acid composition of erythrocyte membrane lipids. 1997 Pediatr. Res. pmid:9396564
Wijendran V et al. Long-chain polyunsaturated fatty acids attenuate the IL-1β-induced proinflammatory response in human fetal intestinal epithelial cells. 2015 Pediatr. Res. pmid:26270575
Groh-Wargo S et al. Body composition in preterm infants who are fed long-chain polyunsaturated fatty acids: a prospective, randomized, controlled trial. 2005 Pediatr. Res. pmid:15718356
Mayes C et al. Variation in [U-13C] alpha linolenic acid absorption, beta-oxidation and conversion to docosahexaenoic acid in the pre-term infant fed a DHA-enriched formula. 2006 Pediatr. Res. pmid:16439591
de la Presa Owens S and Innis SM Diverse, region-specific effects of addition of arachidonic and docosahexanoic acids to formula with low or adequate linoleic and alpha-linolenic acids on piglet brain monoaminergic neurotransmitters. 2000 Pediatr. Res. pmid:10879811
Carnielli VP et al. The very low birth weight premature infant is capable of synthesizing arachidonic and docosahexaenoic acids from linoleic and linolenic acids. 1996 Pediatr. Res. pmid:8798265
Kurlandsky LE et al. The absorption and effect of dietary supplementation with omega-3 fatty acids on serum leukotriene B4 in patients with cystic fibrosis. 1994 Pediatr. Pulmonol. pmid:7838619
Ahmad A et al. Decrease in neuron size in docosahexaenoic acid-deficient brain. 2002 Pediatr. Neurol. pmid:11955929